Latest Articles

Publication Date
TCF21 Identified as Regulator of EMT and Cytoskeletal Changes in Uterine Development and Endometriosis - geneonline.com

TCF21 Identified as Regulator of EMT and Cytoskeletal Changes in Uterine Development and Endometriosis geneonline.com

Published: March 5, 2026, 9:01 a.m.
Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence Contemporary OB/GYN

Published: March 5, 2026, 12:23 a.m.
Endometriosis: Fapohunda leads charge for compassion, policy reform - The Sun Nigeria

Endometriosis: Fapohunda leads charge for compassion, policy reform The Sun Nigeria

Published: March 4, 2026, 11:36 p.m.
Belfast woman's endometriosis dismissed as 'anxiety' during 11 year battle - Belfast Live

Belfast woman's endometriosis dismissed as 'anxiety' during 11 year battle Belfast Live

Published: March 4, 2026, 3:43 p.m.
Living as a nail tech with endometriosis: ‘I was scared of losing my nail business’ - Scratch Magazine

Living as a nail tech with endometriosis: ‘I was scared of losing my nail business’ Scratch Magazine

Published: March 4, 2026, 1:39 p.m.
As Women Wait 7–10 Years for Diagnosis, PRM Expands - GlobeNewswire

As Women Wait 7–10 Years for Diagnosis, PRM Expands GlobeNewswire

Published: March 4, 2026, 1:16 p.m.
As Women Wait 7–10 Years for Diagnosis, PRM Expands Endometriosis Centers of Excellence to Three Major U.S. Cities - Yahoo Finance Singapore

As Women Wait 7–10 Years for Diagnosis, PRM Expands Endometriosis Centers of Excellence to Three Major U.S. Cities Yahoo Finance Singapore

Published: March 4, 2026, 1:16 p.m.
Walking daily to raise awareness of ‘terrible’ disease - Fenland Citizen

Walking daily to raise awareness of ‘terrible’ disease Fenland Citizen

Published: March 4, 2026, 12:01 p.m.
Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis - marketscreener.com

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis marketscreener.com

Published: March 4, 2026, 11:51 a.m.
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - lelezard.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis lelezard.com

Published: March 4, 2026, 10:17 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!